Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Clobetasol propionate+neomycin sulfate+Nystatin |
Is a |
Corticosteroid and/or corticosteroid derivative-containing product |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Is a |
Clobetasol propionate topical preparation |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Clobetasol propionate |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Is a |
Product containing nystatin in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Is a |
Product containing neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Skin antifungal agent |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nystatin (substance) |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Skin anti-infective |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin (substance) |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Has manufactured dose form |
Cutaneous AND/OR transdermal dosage form |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Is a |
Product containing nystatin in topical dosage form |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
Is a |
Product containing neomycin in topical dosage form |
false |
Inferred relationship |
Some |
|
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
|
|